Boothbay Fund Management »

Pelthos Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Pelthos Therapeutics shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Pelthos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pelthos Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pelthos Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $595k 21k 28.00

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Pelthos Therapeutics

Murchinson
Vanguard Group
Ikarian Capital
Boothbay Fund Management
Diadema Partners
Geode Capital Management
Knott David M Jr
Persistent Asset Partners
Steward Partners Investment Advisory
Tower Research Capital
UBS Group
Jpmorgan Chase & Co

View all funds holding Pelthos Therapeutics